MDMA therapy for PTSD in male Israeli veterans
Part of Mental health clinical trials.
This study tests whether MDMA (the drug in Ecstasy) can help male Israeli veterans with PTSD feel better, especially if their symptoms are related to moral injury. It involves therapy sessions and monitoring to see how the drug affects your brain and emotions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male veteran of the Israeli military, at least 18 years old, and fluent in Hebrew.
- You have been diagnosed with PTSD from your service that has lasted 6 months or more, and you've tried at least one prior treatment.
- You must be able to swallow pills, undergo EEG tests (brain monitoring) and have your sessions recorded.
- You need to have a support person (like a family member) who can be contacted if needed, and you must stay overnight after each experimental session.
- You cannot have certain heart problems, liver disease, or be at serious risk of suicide.
- You cannot have used MDMA more than 10 times in the last 10 years or at all in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining MDMA with talk therapy can help people with post-traumatic stress disorder (PTSD) from war experiences. It involves both individual and group therapy sessions, and the medication is given during some sessions.
This study compares MDMA-assisted therapy in a group setting versus individual sessions for people whose PTSD started after the October 7, 2023 events in Israel. You would receive MDMA along with therapy sessions to see which format works best for reducing PTSD symptoms.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.
This trial tests different doses of MDMA (a drug sometimes called 'ecstasy') combined with therapy to see which dose works best for treating PTSD in veterans. The goal is to find a safer, more effective dose to help reduce PTSD symptoms.
Hear when a new Moral Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.